The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Primary myelofibrosis 3
RITUXIMAB Pulmonary toxicity 3
rituximab Respiratory disorder 3
RITUXIMAB Retching 3
RITUXIMAB Splenomegaly 3
Rituximab Stress fracture 3
RITUXIMAB Strongyloidiasis 3
Rituximab Synovial cyst 3
RITUXIMAB Synovitis 3
Rituximab Temporal arteritis 3
Rituximab Thyroid cyst 3
Rituximab Tibia fracture 3
Rituximab Transaminases increased 3
Rituximab Tremor 3
Rituximab Uterine polyp 3
RITUXIMAB Vasculitis 3
RITUXIMAB Viral infection 3
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Haemoglobin decreased 3
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Pain 3
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) Pancytopenia 3

Total Records: 1,104     Number of Pages: 56